PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50118C00015 — PROVIDE A NCE THROUGH 12/15/2022; INCORPORATE COVID-19 LANGUAGE; UPDATE SOW

PROVIDE A NCE THROUGH 12/15/2022; INCORPORATE COVID-19 LANGUAGE; UPDATE SOW is a federal NONE award for Department of Health and Human Services (HHS) held by SPERO THERAPEUTICS, INC.. Estimated value $49.8M ($31.6M obligated). Current period of performance ends Oct 31, 2026. Last award drew 1 bidder.

$49.8M
Estimated Value
$31.6M
Obligated
Oct 31, 2026
PoP End / Expires
1
Bidders (last award)

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

SPERO THERAPEUTICS, INC. holds $23.0M across 2 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Oct 31, 2026 PoP end — agencies typically plan 12–18 months ahead.

Contract facts

NONE
Contract number75A50118C00015
AgencyDepartment of Health and Human Services (HHS)
IncumbentSPERO THERAPEUTICS, INC.
UEINX34PL7NZW24
NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN13
PoP end (current)Oct 31, 2026
Obligated$31.6M

PROVIDE A NCE THROUGH 12/15/2022; INCORPORATE COVID-19 LANGUAGE; UPDATE SOW

Recompete timing

Public
Expiring in 76 days

Current PoP ends Oct 31, 2026 (76 days remaining). Agencies typically plan 12–18 months ahead — at 2.5 months out, that window is already open. The buying decision is likely already in motion.

Watch this contract — one email →

Incumbent footprint

Public record

SPERO THERAPEUTICS, INC.$23.0M obligated across 2 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$23.0M · 100% of firm total
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See the recompete window for 75A50118C00015
More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open SPERO THERAPEUTICS, INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract 75A50118C00015?

75A50118C00015 (PROVIDE A NCE THROUGH 12/15/2022; INCORPORATE COVID-19 LANGUAGE; UPDATE SOW) is a Department of Health and Human Services (HHS) award with an estimated value of $49.8M, currently held by SPERO THERAPEUTICS, INC.. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on 75A50118C00015?

SPERO THERAPEUTICS, INC. is the incumbent with $23.0M across 2 related awards in SCOUT’s public footprint. The current period of performance ends Oct 31, 2026.

When does 75A50118C00015 come up for recompete?

SCOUT tracks a period-of-performance end of Oct 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75A50118C00015